規制動向

FDA、EMA、TGA および世界の規制動向

#4740 ×

2026年9月22日•1分で読めます

FDA Approves Buprenorphine ANDA078633 Sublingual Tablets

FDA has approved an ANDA for buprenorphine sublingual tablets (2 mg and 8 mg) from Hikma Pharmaceuticals USA Inc., with associated labeling and REMS submissions.